Marker TG30 is down regulated in cells positive for mesendoderm marker MIXL1 at day3 post 250 mM SNAP treatment. (c) Differentiation to early mesoderm (day 3) is enhanced in 3D cultures by addition of mitochondrial biogenesis agents. Scale bars are 200 mM. (d) 250 mM SNAP can partially rescue MIXL1 expression on removal of Activin A or BMP4. Control samples were treated according to ([44], black bars) or cultured without BMP 4 (red bars) or without Activin A (blue bars). (e) Mitochondrially associated gene 1676428 expression is highly variable after SNAP and 
AICAR treatment. S, SNAP; A, AICAR; M, metformin; POLG, polymerase gamma; TFAM, mitochondrial transcription factor A; numbers represent mM concentrations of reagents used; D, DMSO without biogenesis agents was added as controls in equal volumes to treated samples. doi:10.1371/journal.pone.0052214.gMitochondrial Lecirelin manufacturer BiogenesisTo test the effect of mitochondria biogenesis agents, SNAP (Snitroso-N-acetylpenicillamine), 15481974 AICAR (5-Aminoimidazole-4-carboxamide 1-b-D-ribofuranoside) and Metformin were added to MIXL1 embryoid bodies or 2D feeder free cultures (GeltrexTM surface coating and StemProH media) at 0?00 mM and cultured for 3 days. Prior to RNA extraction, hESC were harvested with TrypLE SELECT and seeded at 100,000 cells per well of a 24 well plate coated with GeltrexTM in StemProH media. The cells were grown for 2 days in the presence of SNAP, AICAR and Metformin from 0?00 mM before harvesting for RNA as below.HESC In Vitro DifferentiationTo assess the ability of KMEL2 to differentiate, KSR media was exchanged for DMEM without bFGF and supplemented with 10 foetal bovine serum (FBS). Cells were also treated with Retinoic acid (10 mg/mL, Sigma Aldrich), BMP4 (40 ng/mL, R D Systems, Minneapolis, MN, USA) or Activin A (40 ng/mL, PeproTech) for up to 10 days to promote germ layer specific differentiation. For neural specific differentiation, KMEL2 cells were grown feeder free on GeltrexTM to 60 
confluence. Media was changed to KSR supplemented with 100 ng/mL bFGF, 5 mM dorsomorphin, 10uM SB431542 and grown for 6 days with media changed every other day. Cell clumps were treated with collagenase IV to form embryoid bodies and transferred to suspension culture in KSR with bFGF, SB431542 and dorsomorphin for a further 3 days. Embryoid bodies where then grown for up to 30 days prior to plating on mouse laminin (10 mg/cm2, Sigma-Aldrich) coated dishes to allow for neural outgrowth.Quantitative PCR (qPCR)The full protocol used closely adheres to recent guidelines on conducting and reporting on qPCR results [35]. Briefly, RNA was extracted from hESC as single cell cultures using the Qiagen RNeasy RNA extraction kit (Qiagen). Genomic DNA was removed using Turbo DNA-free kit according to the 57773-63-4 manufacturer’s instructions (Life Technologies). One microgram of DNA free RNA was converted to cDNA using Life Technologies’s Superscript III cDNA synthesis kit and oligo (dT)20 primers. CDNA was diluted 1:10 before qPCR. Primer sequences used for qPCR can be found in Table 1. QPCR was performed using an Applied Biosystems 7500 Fast ThermoCycler and SYBRH Green Master Mix with 1 step of 95uC for 20 seconds followed by 40 cycles of 95uC for 3 seconds/60uC for 30 seconds. Primer-product specificity was confirmed by the presence of one peak in a step wise melt curve analysis and visualisation of bands on 1.5 agarose gels. Standard StemProH cultures were used as the control sample and all genes referenced to human b-a.Marker TG30 is down regulated in cells positive for mesendoderm marker MIXL1 at day3 post 250 mM SNAP treatment. (c) Differentiation to early mesoderm (day 3) is enhanced in 3D cultures by addition of mitochondrial biogenesis agents. Scale bars are 200 mM. (d) 250 mM SNAP can partially rescue MIXL1 expression on removal of Activin A or BMP4. Control samples were treated according to ([44], black bars) or cultured without BMP 4 (red bars) or without Activin A (blue bars). (e) Mitochondrially associated gene 1676428 expression is highly variable after SNAP and AICAR treatment. S, SNAP; A, AICAR; M, metformin; POLG, polymerase gamma; TFAM, mitochondrial transcription factor A; numbers represent mM concentrations of reagents used; D, DMSO without biogenesis agents was added as controls in equal volumes to treated samples. doi:10.1371/journal.pone.0052214.gMitochondrial BiogenesisTo test the effect of mitochondria biogenesis agents, SNAP (Snitroso-N-acetylpenicillamine), 15481974 AICAR (5-Aminoimidazole-4-carboxamide 1-b-D-ribofuranoside) and Metformin were added to MIXL1 embryoid bodies or 2D feeder free cultures (GeltrexTM surface coating and StemProH media) at 0?00 mM and cultured for 3 days. Prior to RNA extraction, hESC were harvested with TrypLE SELECT and seeded at 100,000 cells per well of a 24 well plate coated with GeltrexTM in StemProH media. The cells were grown for 2 days in the presence of SNAP, AICAR and Metformin from 0?00 mM before harvesting for RNA as below.HESC In Vitro DifferentiationTo assess the ability of KMEL2 to differentiate, KSR media was exchanged for DMEM without bFGF and supplemented with 10 foetal bovine serum (FBS). Cells were also treated with Retinoic acid (10 mg/mL, Sigma Aldrich), BMP4 (40 ng/mL, R D Systems, Minneapolis, MN, USA) or Activin A (40 ng/mL, PeproTech) for up to 10 days to promote germ layer specific differentiation. For neural specific differentiation, KMEL2 cells were grown feeder free on GeltrexTM to 60 confluence. Media was changed to KSR supplemented with 100 ng/mL bFGF, 5 mM dorsomorphin, 10uM SB431542 and grown for 6 days with media changed every other day. Cell clumps were treated with collagenase IV to form embryoid bodies and transferred to suspension culture in KSR with bFGF, SB431542 and dorsomorphin for a further 3 days. Embryoid bodies where then grown for up to 30 days prior to plating on mouse laminin (10 mg/cm2, Sigma-Aldrich) coated dishes to allow for neural outgrowth.Quantitative PCR (qPCR)The full protocol used closely adheres to recent guidelines on conducting and reporting on qPCR results [35]. Briefly, RNA was extracted from hESC as single cell cultures using the Qiagen RNeasy RNA extraction kit (Qiagen). Genomic DNA was removed using Turbo DNA-free kit according to the manufacturer’s instructions (Life Technologies). One microgram of DNA free RNA was converted to cDNA using Life Technologies’s Superscript III cDNA synthesis kit and oligo (dT)20 primers. CDNA was diluted 1:10 before qPCR. Primer sequences used for qPCR can be found in Table 1. QPCR was performed using an Applied Biosystems 7500 Fast ThermoCycler and SYBRH Green Master Mix with 1 step of 95uC for 20 seconds followed by 40 cycles of 95uC for 3 seconds/60uC for 30 seconds. Primer-product specificity was confirmed by the presence of one peak in a step wise melt curve analysis and visualisation of bands on 1.5 agarose gels. Standard StemProH cultures were used as the control sample and all genes referenced to human b-a.
